5[9]Bressler R, Johnson D. New pharmacological approaches to therapy of NIDDM Diabetes Czre 1992, 15:792
6[10]Lermai, Perez FJG, Aguilar- salinas CA, et al. Acarbose: in search for its real indications in current medical practice. Diabetes Care,1996, 19:94
10[14]Defeo P, Torlone E, Perriello G, et al. Short - term metabolic effects of the ACE - in - hibitor benazepril in type 2 diabetes mellitus associated with arterial hypertension. Diabete et Metab, 1992, 18(4): 283 - 288
6Bistrian BR, Role of the systemic inflammatory response syndrome in the development of protein - calorie malnutrition in ESRD [J].Am J Kidney Dis,1998,32(6 suppl4) :118.
7Qureshi AR,Alvestrand A, Danielsson A, et al. Factors influencing malnutrition in hemodialysis patients [J].A cross - sectional study. Kidney lnt, 1998,53:773.
8Okura Y, Saku K, Hirata K, et al. Serum lipoprotein levels in maintenance hemodialyaia patients[J]. Nephron, 1993,65:46.
9Young GA. Kopple JD, Lindholm B. Nutritional assessment of continuous ambulatory peritoneal dialysis patients[J] .Am J Kidney Dis,1991,17(4):462.
10Foley RN. Parfrey PS, Smsrk M J. Climical epidemiology of cardiovasculaf disease in chronic renal failure[J] .Am J Kidney Dis,1998,32(suppl 5) :112.
